Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Gastric Cancer

  Free Subscription


Articles published in Clin Res Hepatol Gastroenterol

Retrieve available abstracts of 30 articles:
HTML format



Single Articles


    October 2024
  1. WU R, Yuan S, Wang Y, Nan Y, et al
    Efficacy and safety of ramucirumab in gastric or gastroesophageal cancer: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2024;48:102466.
    PubMed     Abstract available


    May 2024
  2. SHI H, Kong S
    A comprehensive evaluation of serum circCSPP1 as a novel diagnostic and prognostic biomarker for gastric cancer.
    Clin Res Hepatol Gastroenterol. 2024;48:102367.
    PubMed     Abstract available


  3. WU N, Ding Y, Huang WF
    A rare case of gastroduodenal glomus tumor.
    Clin Res Hepatol Gastroenterol. 2024;48:102333.
    PubMed    


    April 2024
  4. HAN DG, Wang K, Liu W
    Gastric adenocarcinoma of fundic gland (chief cell predominant) type.
    Clin Res Hepatol Gastroenterol. 2024;48:102306.
    PubMed    


    January 2024
  5. HAN X, Jia X, Sheng C, Li M, et al
    A comparison analysis of the somatic mutations in early-onset gastric cancer and traditional gastric cancer.
    Clin Res Hepatol Gastroenterol. 2024 Jan 20:102287.
    PubMed     Abstract available


  6. XU Y, Song Y, Zhang B, Yang Y, et al
    Clinicopathological characteristics of crawling-type gastric adenocarcinoma.
    Clin Res Hepatol Gastroenterol. 2024;48:102262.
    PubMed    


  7. MARTIN A, Jauvain M, Bergsten E, Demontant V, et al
    Gastric microbiota in patients with gastric MALT lymphoma according to Helicobacter pylori infection.
    Clin Res Hepatol Gastroenterol. 2024;48:102247.
    PubMed     Abstract available


    November 2023
  8. DEPOTTE L, Palle J, Rasola C, Broudin C, et al
    New developments and standard of care in the management of advanced gastric cancer.
    Clin Res Hepatol Gastroenterol. 2023 Nov 10:102245.
    PubMed     Abstract available


    August 2023
  9. DU C, He Z, Li L, Ning B, et al
    Endoscopic resection for the treatment of non-gastric gastrointestinal stromal tumors: A retrospective study from a large tertiary hospital in China.
    Clin Res Hepatol Gastroenterol. 2023;47:102152.
    PubMed     Abstract available


    January 2023
  10. WANG M, Su J, Lu J, Yang Z, et al
    Efficacy and safety of HER2-targeted therapy in patients with colorectal cancer: What should we expect from a meta-analysis?
    Clin Res Hepatol Gastroenterol. 2023;47:102078.
    PubMed     Abstract available


    December 2022
  11. YUAN H, Duan DD, Zhang YJ
    Comprehensive analysis of treatment-related adverse events of immunotherapy in advanced gastric or gastroesophageal junction cancer: A meta-analysis of randomized controlled trials.
    Clin Res Hepatol Gastroenterol. 2022;46:102031.
    PubMed     Abstract available


    October 2022
  12. WU H, Jiang HJ, Wang SL, Chen XY, et al
    Impact of metabolic syndrome on the short- and long-term outcomes for the elderly patients with gastric cancer after radical gastrectomy.
    Clin Res Hepatol Gastroenterol. 2022;46:102041.
    PubMed     Abstract available


    May 2022
  13. MA N, Qiao H, Tao H, Gan X, et al
    Treatment response, survival, and safety profile of camrelizumab plus apatinib regimen as third-line treatment in metastatic gastric cancer patients.
    Clin Res Hepatol Gastroenterol. 2022 May 27:101962.
    PubMed     Abstract available


  14. SIRMAI L, Benusiglio PR, Svrcek M, Dray X, et al
    Magnifying chromoendoscopy with targeted biopsies of intramucosal signet cell adenocarcinomas in a CDH1 pathogenic variant asymptomatic carrier.
    Clin Res Hepatol Gastroenterol. 2022;46:101914.
    PubMed    


    April 2022
  15. CARBONI F, Zazza S, Bertini L, Diodoro MG, et al
    Remarkable survival of operated stage IV gastric cancer with resected late isolated colon metastasis.
    Clin Res Hepatol Gastroenterol. 2022 Apr 7:101917.
    PubMed     Abstract available


  16. NG HI, Li ZQ, Zhang YM, Hu CF, et al
    Gastric inverted hyperplastic polyp, an exceptional case diagnosed after endoscopic submucosal dissection.
    Clin Res Hepatol Gastroenterol. 2022;46:101890.
    PubMed     Abstract available


    March 2022
  17. HE T, Yu D, Wang Z, Guo C, et al
    Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: a long-term follow-up study.
    Clin Res Hepatol Gastroenterol. 2022 Mar 25:101913.
    PubMed     Abstract available


  18. LI J, Huang WF, Zhang JY
    A rare case of duodenal neuroendocrine tumor with hepatic metastasis.
    Clin Res Hepatol Gastroenterol. 2022;46:101850.
    PubMed    


  19. JENVRIN A, Lepine C, Bozec PL, Taieb J, et al
    Atypical cutaneous metastases of poorly cohesive carcinoma of the stomach: Letter to the editor.
    Clin Res Hepatol Gastroenterol. 2022;46:101795.
    PubMed    


    October 2021
  20. TAJA-CHAYEB L, Vidal-Millan S, Trejo-Becerril C, Perez-Cardenas E, et al
    Hereditary Diffuse Gastric Cancer (HDGC). An overview.
    Clin Res Hepatol Gastroenterol. 2021 Oct 14:101820.
    PubMed     Abstract available


    September 2021
  21. BOEKEN T, Gallois C, Douard R, Meatchi T, et al
    Bridge to surgery after irinotecan-based liver chemoembolization for metastatic gastric adenocarcinoma: Letter to the editor.
    Clin Res Hepatol Gastroenterol. 2021;45:101557.
    PubMed    


    July 2021
  22. LIU H, Liu M, He B, Li Q, et al
    Inhibition of USP11 sensitizes gastric cancer to chemotherapy via suppressing RhoA and Ras-mediated signaling pathways.
    Clin Res Hepatol Gastroenterol. 2021 Jul 28:101779.
    PubMed     Abstract available


  23. TRAN-MINH ML, Lehmann-Che J, Lambert J, Theou-Anton N, et al
    Prevalence and prognosis of microsatellite instability in oesogastric adenocarcinoma, NORDICAP 16-01.
    Clin Res Hepatol Gastroenterol. 2021;45:101691.
    PubMed     Abstract available


    June 2021
  24. HOU B, Wang P, Liu T, Chen S, et al
    Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Gastric Cancer Patients Treated with Immune Checkpoint Inhibitors.
    Clin Res Hepatol Gastroenterol. 2021 Jun 25:101748.
    PubMed     Abstract available


    May 2021
  25. DOUMBE-MANDENGUE P, Beuvon F, Belle A, Dermine S, et al
    Outcomes of endoscopic submucosal dissection for early esophageal and gastric cardia adenocarcinomas.
    Clin Res Hepatol Gastroenterol. 2021;45:101700.
    PubMed     Abstract available


    March 2021
  26. BU X, Chen Z, Zhang A, Zhang X, et al
    Circular RNA CircAFF2 Accelerates Gastric Cancer Development by Activating MiR-6894-5p and Regulating ANTXR 1 Expression.
    Clin Res Hepatol Gastroenterol. 2021 Mar 12:101671.
    PubMed     Abstract available


  27. JIN P, Ji X, Ma S, Kang W, et al
    Adjuvant chemotherapy indications for stage I gastric cancer patients with negative lymph node.
    Clin Res Hepatol Gastroenterol. 2021;45:101634.
    PubMed     Abstract available


    January 2021
  28. CARBONE R, Vanoli A, Rovedatti L, Lucioni M, et al
    Epstein-Barr virus negative smooth muscle neoplasm of the stomach in a young woman.
    Clin Res Hepatol Gastroenterol. 2021;45:101471.
    PubMed     Abstract available


    November 2020
  29. YAN XL, Luo QY, Zhou SN, Pan WT, et al
    MicroRNA-375 reverses the expression of PD-L1 by inactivating the JAK2/STAT3 signaling pathways in gastric cancer.
    Clin Res Hepatol Gastroenterol. 2020 Nov 30:101574.
    PubMed     Abstract available


  30. LU J, Ma Y, Zhao Z
    MiR-142 suppresses progression of gastric carcinoma via directly targeting LRP8.
    Clin Res Hepatol Gastroenterol. 2020 Nov 29:101520.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.